Molly Brady brings more than 15 years of experience to her work in infectious diseases, with a focus on strategy development and monitoring and evaluation (M&E) of neglected tropical diseases (NTDs) in Africa, Asia, and Latin America. She is a global expert on lymphatic filariasis (LF), also known as elephantiasis, a mosquito-borne illness that causes disfiguring swelling of limbs and genitals.
In her current role, Ms. Brady serves as a senior advisor for NTDs on USAID’s Act to End NTDs | East program, providing technical assistance to LF-endemic countries on a range of programmatic areas, including achieving coverage targets for mass drug administration, implementing quality surveys, and documenting evidence towards elimination of LF as a public health problem. She brings lessons learned from national programs into dialogue to develop and revise global guidance.
Ms. Brady is a globally recognized expert in lymphatic filariasis and has made significant contributions to the development of global tools for addressing LF morbidity and evolving M&E for LF programs. She is a member of the Global Alliance to Eliminate LF (GAELF) Steering Committee and past Chair of the LF Non-governmental Development Organization (NGDO) Network.
